Hanlon Investment Management, Inc. Medpace Holdings, Inc. Transaction History

Hanlon Investment Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$372.0 - $424.34 $17,484 - $19,943	47 Added 2.01%	2,383 $981,000
Q1 2024 May 01, 2024	SELL	$284.87 - $413.31 $57,258 - $83,075	-201 Reduced 7.92%	2,336 $944,000
Q4 2023 Feb 09, 2024	SELL	$227.52 - $312.68 $162,221 - $222,940	-713 Reduced 21.94%	2,537 $777,000
Q3 2023 Oct 18, 2023	BUY	$233.98 - $281.67 $760,435 - $915,427	3,250 New	3,250 $786,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Hanlon Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hanlon Investment Management, Inc. with notifications on news.